<DOC>
	<DOCNO>NCT01499485</DOCNO>
	<brief_summary>The purpose study analyze whether treatment metabolic alkalosis acetazolamide intubate patient chronic obstructive pulmonary disease ( COPD ) obesity hypoventilation syndrome ( OHS ) reduce length mechanical ventilation ( MV ) .</brief_summary>
	<brief_title>Treatment Metabolic Alkalosis With Acetazolamide . Effect Length Mechanical Ventilation .</brief_title>
	<detailed_description>Metabolic alkalosis ( MA ) may reduce central respiratory drive , cardiac output worsen oxygenation , leading delay wean MV . Acetazolamide carbonic anhydrase inhibitor able correct MA stimulate respiratory drive . There paucity study outcome patient MA MV treat acetazolamide . The primary objective study analyze whether treatment MA acetazolamide intubate patient COPD OHS reduce length MV , reduce length ICU stay ICU mortality . Complications associate acetazolamide treatment also analyze . Phase III double-blinded trial , COPD OHS patient MV pH &gt; 7,35 bicarbonate &gt; 28 mEq/L . Patients randomize receive 500 mg acetazolamide placebo . According arterial blood gas analysis ( ABGA ) value treatment administration evaluate daily extubation .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Hypoventilation</mesh_term>
	<mesh_term>Obesity Hypoventilation Syndrome</mesh_term>
	<mesh_term>Alkalosis</mesh_term>
	<mesh_term>Acetazolamide</mesh_term>
	<criteria>Patients COPD obesity hypoventilation syndrome invasive mechanical ventilation le 72 h metabolic alkalosis , define pH &gt; 7.35 actual bicarbonate &gt; 28 mmol/L , potassium plasmatic level &gt; = 4 mEq/L . Postoperative patient . Previous psychiatric disease . Epilepsy . Pregnancy . Hepatic cirrhosis . Sulfonamide acetazolamide allergy . Plasmatic creatinine &gt; 2.5 mg/dL creatinine clearance &lt; 20 mL/min continuous renal replacement technique . Intolerance enteral feeding . Administration previous 72 h bicarbonate acetazolamide . Terminal disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Pulmonary Disease , Chronic Obstructive</keyword>
	<keyword>Obesity Hypoventilation Syndrome</keyword>
	<keyword>Alkalosis</keyword>
	<keyword>Respiration , Artificial</keyword>
	<keyword>Acetazolamide</keyword>
	<keyword>Intensive care</keyword>
	<keyword>Adult</keyword>
</DOC>